Section Arrow
SRPT.NASDAQ
- Sarepta Therapeutics
Quotes are at least 15-min delayed:2024/12/25 01:26 EST
Last
 121.9
+1.24 (+1.03%)
Day High 
122.1808 
Prev. Close
120.66 
1-M High
138.81 
Volume 
204.86K 
Bid
119
Ask
122.4
Day Low
120 
Open
120.21 
1-M Low
113 
Market Cap 
11.53B 
Currency USD 
P/E 78.35 
%Yield -- 
10-SMA 123.22 
20-SMA 125.63 
50-SMA 122.95 
52-W High 173.25 
52-W Low 91.3439 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.54/12.04
Enterprise Value
12.80B
Balance Sheet
Book Value Per Share
12.78
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.24B
Operating Revenue Per Share
11.57
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TNXPTonix Pharmaceuticals Holding Corp.0.3853-0.0178-4.42%-- 
CMNDClearmind Medicine1.72+0.5+40.98%0.16PE
CEROCERo Therapeutics Holdings0.0623+0.0118+23.37%-- 
ATNF180 Life Sciences Corp2.9+1.03+55.08%0.23PE
RXRXRecursion Pharmaceuticals7.24+0.25+3.58%-- 
Quotes are at least 15-min delayed:2024/12/25 01:26 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.